Medicine and HealthNature Communications
Ultrasound-controllable engineered bacteria for cancer immunotherapy
M. H. Abedi, M. S. Yao, et al.
This groundbreaking research by Mohamad H Abedi and team explores the innovative use of genetically engineered microbes as cancer therapeutics controlled by focused ultrasound, showcasing their ability to specifically target tumors and release immune checkpoint inhibitors upon activation.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
Y. Yoshinami and H. Shoji
Biology
Programming gene expression in multicellular organisms for physiology modulation through engineered bacteria
B. Gao and Q. Sun
Medicine and Health
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
M. Luu, Z. Riester, et al.
Medicine and Health
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
Y. Jiang, J. Huang, et al.
